Position in PFE
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$333,580
-$118,564 QoQ
Shares Held
13,853
-14.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#2,050
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Stratos Investment Management, LLC holds $63,598,115 across 8 Drug Manufacturers - General names. PFE ranks #7 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
17,200 | $20,630,197 | |
| 2 | MRK |
Merck & Co., Inc.
|
147,259 | $18,922,781 | |
| 3 | ABBV |
AbbVie Inc.
|
35,937 | $9,043,186 | |
| 4 | AMGN |
Amgen Inc
|
23,940 | $8,669,152 | |
| 5 | JNJ |
Johnson & Johnson
|
20,901 | $5,308,226 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
3,199 | $404,161 | |
| 7 | PFE |
Pfizer Inc
This page
|
13,853 | $333,580 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
4,978 | $286,832 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $333,580 | 13,853 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $452,144 | 16,102 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $372,653 | 14,966 | Shares | Sole | 2026-01-20 | |
| 2025-09-30 | $404,928 | 15,892 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $395,766 | 16,327 | Shares | Sole | 2025-07-29 | |
| 2025-03-31 | $425,255 | 16,782 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $542,007 | 20,430 | Shares | Sole | 2025-01-27 | |
| 2024-09-30 | $432,016 | 14,928 | Shares | Sole | 2024-10-17 | |
| 2024-06-30 | $361,361 | 12,915 | Shares | Sole | 2024-07-24 | |
| 2024-03-31 | $427,183 | 15,394 | Shares | Sole | 2024-04-16 | |
| 2023-12-31 | $5,012,598 | 174,109 | Shares | Sole | 2024-01-24 | |
| 2023-09-30 | $5,297,647 | 159,712 | Shares | Sole | 2023-10-24 | |
| 2023-06-30 | $5,133,586 | 139,956 | Shares | Sole | 2023-07-18 | |
| 2023-03-31 | $5,557,939 | 136,224 | Shares | Sole | 2023-05-01 | |
| 2022-12-31 | $7,556,567 | 147,474 | Shares | Sole | 2023-01-19 | |
| 2022-09-30 | $6,409,264 | 146,464 | Shares | Sole | 2022-10-24 | |
| 2022-06-30 | $8,194,494 | 156,294 | Shares | Sole | 2022-09-06 | |
| 2022-03-31 | $7,913,406 | 152,857 | Shares | Sole | 2022-04-26 | |
| 2021-12-31 | $9,654,793 | 163,502 | Shares | Sole | 2022-01-14 | |
| 2021-09-30 | $6,708,011 | 155,964 | Shares | Sole | 2021-10-19 | |
| 2021-06-30 | $5,199,155 | 132,767 | Shares | Sole | 2021-07-19 | |
| 2021-03-31 | $4,361,947 | 120,396 | Shares | Sole | 2021-04-27 | |
| 2020-12-31 | $4,628,967 | 125,753 | Shares | Sole | 2021-01-29 | |
| 2020-09-30 | $4,192,970 | 114,250 | Shares | Sole | 2020-10-29 | |
| 2020-06-30 | $3,466,170 | 105,999 | Shares | Sole | 2020-07-28 | |
| 2020-03-31 | $2,919,285 | 89,439 | Shares | Sole | 2020-05-04 | |
| No filing history on record for this holder in this stock. | ||||||